SEC Filing · 144
Travere Therapeutics, Inc.
TVTXNASDAQEQUITYCurrent
SEC Filing
Company context
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent - that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope - today and tomorrow. For more information, visit travere.com.
Current securities
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗